{"gene":"MKRN3","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2013,"finding":"Loss-of-function mutations in MKRN3 (frameshift and missense) cause central precocious puberty in humans; MKRN3 mRNA is high in the arcuate nucleus of prepubertal mice and decreases immediately before puberty, establishing an inhibitory role on GnRH secretion.","method":"Whole-exome sequencing, Sanger sequencing, quantitative real-time PCR in mouse hypothalami at different ages","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple families with segregation analysis consistent with imprinted inheritance, mRNA expression profiling across developmental stages, replicated extensively across subsequent studies","pmids":["23738509"],"is_preprint":false},{"year":1999,"finding":"The mouse Zfp127 (Mkrn3) gene is differentially methylated with the maternal allele methylated and the paternal allele unmethylated; maternal methylation is established promptly after fertilization prior to syngamy; in methyltransferase-deficient mice Zfp127 is biallelically expressed, demonstrating that methylation enforces paternal-only expression.","method":"Bisulfite sequencing / methylation analysis, methyltransferase-deficient mouse model, expression analysis","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct methylation mapping and genetic model (methyltransferase-deficient mice) with functional consequence on monoallelic expression","pmids":["10395905"],"is_preprint":false},{"year":2017,"finding":"MKRN3 (Mkrn3) functions as an E3 ubiquitin ligase that interacts with and polyubiquitinates Nptx1 (neural pentraxin 1) in the mouse hypothalamus; the RING finger domain of Mkrn3 is required for binding Nptx1 and catalyzing its polyubiquitination; Mkrn3 and Nptx1 show inverse expression patterns in the hypothalamus around puberty initiation.","method":"Co-immunoprecipitation, ubiquitination assay, RING finger domain deletion analysis, expression profiling in mouse hypothalamus","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and in vitro ubiquitination assay with domain deletion, single lab","pmids":["29156706"],"is_preprint":false},{"year":2019,"finding":"Hypothalamic miR-30b directly represses Mkrn3 via three binding sites in a highly conserved region of the Mkrn3 3' UTR; hypothalamic miR-30b expression increases while Mkrn3 protein decreases during rat postnatal maturation; central infusion of target site blockers preventing miR-30 binding to Mkrn3 3' UTR reversed the prepubertal decline in hypothalamic Mkrn3 protein and delayed female puberty onset.","method":"In vitro luciferase reporter assay (3' UTR), central infusion of target site blockers (TSBs) in juvenile rats, western blot, qPCR","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — functional luciferase validation plus in vivo TSB intervention with direct phenotypic readout, multiple orthogonal methods","pmids":["31697675"],"is_preprint":false},{"year":2019,"finding":"MKRN3 interacts with 81 high-confidence protein partners identified by mass spectrometry in HEK cells, including proteins involved in insulin signaling, RNA metabolism, and cell-cell adhesion, of which 20 have been previously implicated in puberty timing. MKRN3 knockout in human iPSC-derived GnRH neurons did not alter GNRH1 expression (negative finding).","method":"Stable expression in HEK cells followed by mass spectrometry (AP-MS), human iPSC differentiation into GnRH neurons with CRISPR knockout","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-based interactome screen with stable expression, plus negative functional result in iPSC model, single lab","pmids":["30800097"],"is_preprint":false},{"year":2020,"finding":"MKRN3 is expressed in Kiss1 neurons of the mouse hypothalamic arcuate nucleus and represses promoter activity of human KISS1 and TAC3. MKRN3 has intrinsic ubiquitinase (E3 ligase) activity, which is reduced by mutations affecting the RING finger domain; these RING finger mutations also compromise repression of KISS1 and TAC3 promoter activity. MKRN3 expression in the hypothalamus of rats and non-human primates is high early in life and decreases as puberty approaches, independent of sex steroids.","method":"In situ hybridization (Mkrn3 and Kiss1 co-localization), luciferase promoter reporter assays (KISS1 and TAC3), in vitro ubiquitination assay, RING finger domain mutagenesis, expression profiling across developmental stages in multiple species","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (co-localization, reporter assay, in vitro ubiquitination, mutagenesis) in a single rigorous study","pmids":["32407292"],"is_preprint":false},{"year":2020,"finding":"MKRN3 interacts with and ubiquitinates MBD3 (methyl-CpG binding domain protein 3); this ubiquitination disrupts MBD3 binding to the GNRH1 promoter and prevents recruitment of DNA demethylase TET2, thereby epigenetically silencing GNRH1 transcription. Genetic ablation of Mkrn3 in mice accelerates puberty onset with increased hypothalamic GnRH1 production.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, chromatin immunoprecipitation, Mkrn3 knockout mouse model, hypothalamic GnRH1 quantification","journal":"National science review","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — Co-IP, ubiquitination assay, ChIP, and in vivo knockout with phenotypic readout in single study, multiple orthogonal methods","pmids":["34692086"],"is_preprint":false},{"year":2021,"finding":"MKRN3 ubiquitinates three poly(A)-binding proteins (PABPC1, PABPC3, and PABPC4); this ubiquitination attenuates PABP binding to poly(A) tails of mRNA, shortens the poly(A) tail length of GNRH1 mRNA, and compromises formation of the translation initiation complex, thereby suppressing GNRH1 mRNA translation.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, poly(A) tail length assay, translation initiation complex analysis, mass spectrometry substrate identification","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of ubiquitination, poly(A) tail assay, and TIC assay; multiple orthogonal methods in single study","pmids":["33744966"],"is_preprint":false},{"year":2021,"finding":"MKRN3 functions as a tumor suppressor E3 ubiquitin ligase in non-small cell lung cancer (NSCLC); PABPC1 was identified as a major substrate for MKRN3 via mass spectrometry proteomics. MKRN3 modulates cell proliferation through nonproteolytic (non-K48) ubiquitination of PABPC1 and subsequent suppression of PABPC1-mediated global protein synthesis. MKRN3 missense mutations identified in patients substantially compromise MKRN3-mediated PABPC1 ubiquitination. Mkrn3 knockout mice show increased susceptibility to urethane-induced lung cancer.","method":"Mass spectrometry proteomics, in vitro ubiquitination assay, western blot, reconstitution of MKRN3 in knockout cells, MKRN3 knockout mouse (urethane-induced and lung cell-specific), tumor xenograft","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — MS substrate identification, in vitro ubiquitination, multiple in vivo models (two KO mouse models, xenograft), reconstitution experiments","pmids":["34143182"],"is_preprint":false},{"year":2023,"finding":"MKRN3 interacts with IGF2BP1 (insulin-like growth factor 2 mRNA-binding protein 1), identified by proteomics; IGF2BP1 in turn interacts with polyadenylate-binding protein family members. Mkrn3 deletion in a mouse model leads to early puberty onset in female mice and increases dendritic spine number in the arcuate nucleus without altering GnRH neuron morphology. Mkrn3 deletion also results in significant changes in expression of genes controlling hypothalamic development and plasticity in human iPSC-derived hypothalamic neurons. Neurokinin B (NKB) was identified as an Mkrn3 target.","method":"Proteomics (interactome analysis), CRISPR knockout mouse model, Golgi staining / spine density analysis, human iPSC-derived hypothalamic neurons with MKRN3 deletion, transcriptomics","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — interactome proteomics plus in vivo KO phenotype and iPSC model, single lab, multiple orthogonal methods","pmids":["37092553"],"is_preprint":false},{"year":2018,"finding":"A heterozygous 4-nucleotide deletion in the proximal promoter region of MKRN3 (c.-150_-147delTCAG) reduces MKRN3 promoter activity in GT1-7 cells as demonstrated by luciferase reporter assay; in silico analysis predicts loss of a DREAM transcription factor binding site.","method":"Luciferase reporter assay in GT1-7 cells, Sanger sequencing, in silico transcription factor binding analysis","journal":"Neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay with mutant and wild-type promoter constructs, single lab, single method","pmids":["29763903"],"is_preprint":false},{"year":2019,"finding":"Novel mutations in the proximal promoter region of MKRN3 (-166, -865, -886 nt upstream of TSS) significantly reduce MKRN3 promoter activity in GN11 cells as shown by luciferase reporter assay; a 5'-UTR mutation (+13 nt downstream of TSS) is predicted to destabilize mRNA secondary structure by in silico analysis.","method":"Luciferase reporter assay in GN11 cells, Sanger sequencing, in silico mRNA secondary structure analysis","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter assay with multiple mutant constructs, single lab","pmids":["31636607"],"is_preprint":false},{"year":2023,"finding":"Novel MKRN3 missense mutations within the RING finger domain reduced ubiquitination activity compared to wild-type MKRN3, whereas mutations outside the RING finger domain increased ubiquitination, revealing distinct domain-dependent effects on E3 ligase activity.","method":"Western blot ubiquitination assay with mutant and wild-type MKRN3 constructs","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro ubiquitination assay with multiple mutant constructs, single lab, single method","pmids":["36916482"],"is_preprint":false},{"year":2021,"finding":"A novel MKRN3 missense mutation (p.Gly93Ser) attenuates MKRN3 auto-ubiquitination and degradation, and reduces inhibition of GNRH1, KISS1, and TAC3 promoter transcriptional activity, establishing it as a loss-of-function mutation that compromises MKRN3's repression of GnRH-related signaling.","method":"In vitro ubiquitination assay, luciferase promoter reporter assays (GNRH1, KISS1, TAC3)","journal":"Frontiers in genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays with ubiquitination and reporter assay, single lab, two orthogonal methods","pmids":["34421985"],"is_preprint":false},{"year":2023,"finding":"A novel MKRN3 variant (p.Arg327His) attenuates MKRN3 auto-ubiquitination, degradation, and inhibition of GNRH1 transcriptional and translational activity, confirming loss-of-function for this variant.","method":"In vitro ubiquitination assay, luciferase reporter assay, translational activity assay","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays (ubiquitination, transcription, translation), single lab","pmids":["38054352"],"is_preprint":false},{"year":2025,"finding":"MKRN3 (RNF63) directly interacts with STAT3 and promotes its K48-linked polyubiquitination and proteasome-mediated degradation in NSCLC cells; scaffold protein DLG4 recruits RNF63/MKRN3 to STAT3 to facilitate this ubiquitination. In human NSCLC specimens, DLG4 and RNF63 expression levels are inversely correlated with STAT3 levels.","method":"Affinity purification mass spectrometry, co-immunoprecipitation, denaturation-IP (ubiquitination assay), immunohistochemistry, cell proliferation assays","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, denaturation-IP for ubiquitination, AP-MS substrate identification, single lab","pmids":["40619404"],"is_preprint":false},{"year":2023,"finding":"The CpG island within the Mkrn3 promoter shows significantly lower methylation levels at the pre-pubertal stage compared to pubertal or post-pubertal stages in female mouse hypothalamus, suggesting differential promoter methylation regulates Mkrn3 expression during puberty. In silico analysis identified 14 transcriptional repressors among 29 predicted transcription factor binding sites in the CpG islet region.","method":"Bisulfite sequencing of mouse hypothalamus at multiple developmental stages, CpG mapping, in silico transcription factor binding analysis","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct bisulfite sequencing across developmental time points in vivo, single lab","pmids":["36714607"],"is_preprint":false},{"year":2023,"finding":"Mkrn3 mRNA is expressed in testes and ovaries of mice at all ages; testicular Mkrn3 is expressed primarily in the interstitial (Leydig cell) compartment; testicular Mkrn3 expression peaks peripubertally in males and is upregulated by LH/hCG stimulation in a dose-dependent manner in primary Leydig cell cultures; acute GnRH agonist administration increases testicular Mkrn3, while chronic GnRH agonist suppresses it.","method":"RT-qPCR in gonads across developmental stages, in vitro hCG treatment of primary Leydig cell cultures, in vivo acute and chronic GnRH agonist administration in adult mice","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro LH/hCG dose-response and in vivo pharmacological manipulation with mRNA readout, single lab","pmids":["37585624"],"is_preprint":false},{"year":2025,"finding":"MKRN3 (RNF63) ubiquitinates CSDE1 (cold shock domain-containing E1) via proteolytic (degradative) ubiquitination, identified as a major substrate in ovarian cancer cells by mass spectrometry proteomics; MKRN3-mediated CSDE1 degradation suppresses OC cell proliferation; ovary-specific Mkrn3 knockout in mice accelerates P53 inactivation-induced tumorigenesis.","method":"Mass spectrometry proteomics, in vitro ubiquitination assay, ovary-specific conditional knockout mouse model, tumor xenograft, in vitro proliferation assays","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — MS substrate identification, ubiquitination assay, in vivo conditional KO mouse, single lab","pmids":["42204155"],"is_preprint":false},{"year":2025,"finding":"Zearalenone (ZEA) treatment of hypothalamic GT1-7 cells triggers MKRN3 auto-ubiquitination and down-regulation, which leads to increased GnRH production and cell proliferation; GPER (G protein-coupled estrogen receptor) re-localization is associated with this effect and GPER overexpression attenuates ZEA-induced changes.","method":"In vitro cell treatment (GT1-7 cells), ubiquitination assay, GnRH quantification, GPER localization analysis, GPER overexpression rescue experiment","journal":"Toxicology research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single in vitro system, single lab, mechanistic link between auto-ubiquitination and GnRH effects is indirect","pmids":["40726759"],"is_preprint":false}],"current_model":"MKRN3 is a paternally expressed, maternally imprinted E3 ubiquitin ligase that acts as a brake on puberty initiation by repressing GnRH secretion through multiple mechanisms: it is expressed in hypothalamic Kiss1 neurons where it represses KISS1 and TAC3 promoter activity via its RING finger-dependent ubiquitinase activity; it epigenetically silences GNRH1 transcription by ubiquitinating MBD3 to disrupt TET2 recruitment; it suppresses GNRH1 mRNA translation by ubiquitinating poly(A)-binding proteins (PABPC1/3/4) to shorten poly(A) tails and impair translation initiation; it interacts with IGF2BP1 and regulates hypothalamic plasticity; and its hypothalamic expression—enforced by differential DNA methylation (maternal allele methylated) and regulated post-transcriptionally by miR-30b—declines before puberty onset, thereby permitting GnRH secretion to rise; loss-of-function mutations in MKRN3 are the most common known genetic cause of familial central precocious puberty."},"narrative":{"mechanistic_narrative":"MKRN3 is a paternally expressed, maternally imprinted RING-finger E3 ubiquitin ligase that acts as a developmental brake on puberty initiation by restraining hypothalamic GnRH secretion [PMID:23738509, PMID:32407292]. Its monoallelic expression is enforced by differential DNA methylation, with the maternal allele methylated and the paternal allele active, established shortly after fertilization [PMID:10395905]. MKRN3 is expressed in Kiss1 neurons of the arcuate nucleus, where its RING-finger-dependent ubiquitinase activity represses transcription from the KISS1 and TAC3 promoters [PMID:32407292]. It silences the GnRH axis through multiple converging mechanisms: it ubiquitinates the methyl-CpG-binding protein MBD3 to block TET2 recruitment and epigenetically repress GNRH1 transcription [PMID:34692086], and it ubiquitinates the poly(A)-binding proteins PABPC1/3/4 to shorten GNRH1 mRNA poly(A) tails and impair translation initiation [PMID:33744966]. Hypothalamic MKRN3 protein is high early in life and declines before puberty; this decline is driven by miR-30b, which directly represses MKRN3 via conserved 3'UTR sites, and blocking miR-30 binding sustains MKRN3 and delays puberty [PMID:31697675]. Loss-of-function mutations in MKRN3 — frameshift, missense, and promoter variants that reduce its expression or RING-dependent ligase activity — are a common genetic cause of familial central precocious puberty, and genetic ablation of Mkrn3 in mice accelerates puberty onset [PMID:23738509, PMID:34692086, PMID:34421985]. Beyond the reproductive axis, MKRN3 functions as a tumor-suppressor E3 ligase, ubiquitinating PABPC1, STAT3, and CSDE1 to restrain cell proliferation [PMID:34143182, PMID:40619404, PMID:42204155].","teleology":[{"year":1999,"claim":"Before MKRN3's function was known, the basis of its monoallelic expression was unresolved; this established that genomic imprinting via maternal-allele DNA methylation enforces paternal-only expression.","evidence":"Bisulfite methylation mapping and methyltransferase-deficient mouse model with allelic expression analysis","pmids":["10395905"],"confidence":"High","gaps":["Did not connect imprinted expression to any physiological function","Methylation dynamics in human hypothalamus not addressed"]},{"year":2013,"claim":"The physiological role of MKRN3 was unknown until human genetics linked it to puberty; this established MKRN3 as an inhibitory brake on GnRH secretion whose loss causes central precocious puberty.","evidence":"Whole-exome and Sanger sequencing in families with central precocious puberty plus developmental qPCR of mouse hypothalamus","pmids":["23738509"],"confidence":"High","gaps":["Molecular mechanism of inhibition not defined","Cellular site of action within hypothalamus not pinpointed"]},{"year":2017,"claim":"How MKRN3 acts biochemically was unclear; this provided the first evidence that MKRN3 is an active E3 ligase, polyubiquitinating Nptx1 via its RING finger in the hypothalamus.","evidence":"Reciprocal Co-IP, in vitro ubiquitination assay, and RING-domain deletion in mouse hypothalamus","pmids":["29156706"],"confidence":"Medium","gaps":["Link between Nptx1 ubiquitination and GnRH secretion not established","Single lab, no in vivo loss-of-function for this substrate"]},{"year":2019,"claim":"What drives the prepubertal fall in MKRN3 was unknown; this identified miR-30b as a direct post-transcriptional repressor whose blockade sustains MKRN3 and delays puberty.","evidence":"3'UTR luciferase reporter assays plus central infusion of target-site blockers in juvenile rats with phenotypic readout","pmids":["31697675"],"confidence":"High","gaps":["Upstream control of miR-30b induction unknown","Interplay with promoter methylation not resolved"]},{"year":2019,"claim":"The MKRN3 interactome and its requirement in GnRH neurons were undefined; this catalogued 81 candidate partners and showed MKRN3 knockout in iPSC-derived GnRH neurons did not alter GNRH1, indicating action upstream rather than cell-autonomously in GnRH neurons.","evidence":"AP-MS interactome in HEK cells plus CRISPR knockout in human iPSC-derived GnRH neurons","pmids":["30800097"],"confidence":"Medium","gaps":["Most interactions unvalidated and possibly overexpression artifacts","Negative GNRH1 result not mechanistically explained"]},{"year":2020,"claim":"The cellular site and direct transcriptional targets were uncertain; this localized MKRN3 to arcuate Kiss1 neurons and demonstrated RING-dependent repression of KISS1 and TAC3 promoters with conserved cross-species developmental decline.","evidence":"In situ co-localization, KISS1/TAC3 luciferase reporters, in vitro ubiquitination, RING mutagenesis across rodent and primate developmental stages","pmids":["32407292"],"confidence":"High","gaps":["Direct ubiquitination substrate linking to KISS1/TAC3 repression not identified in this study","Mechanism of promoter repression incompletely defined"]},{"year":2020,"claim":"How MKRN3 silences GNRH1 transcription was unknown; this showed MKRN3 ubiquitinates MBD3 to block TET2 recruitment and demethylation of the GNRH1 promoter, with Mkrn3 knockout accelerating puberty in vivo.","evidence":"Co-IP, in vitro ubiquitination, ChIP, and Mkrn3 knockout mouse with hypothalamic GnRH1 quantification","pmids":["34692086"],"confidence":"High","gaps":["Linkage type of MBD3 ubiquitination not detailed","Relative contribution versus translational control unresolved"]},{"year":2021,"claim":"A translational mode of GnRH suppression was undefined; this showed MKRN3 ubiquitinates PABPC1/3/4 to shorten GNRH1 poly(A) tails and impair translation initiation complex formation.","evidence":"Co-IP, in vitro ubiquitination, poly(A) tail length assay, translation initiation complex analysis, MS substrate identification","pmids":["33744966"],"confidence":"High","gaps":["In vivo confirmation of GNRH1 translation effect not shown","Selectivity for GNRH1 mRNA over global mRNA not fully resolved"]},{"year":2021,"claim":"Whether MKRN3 has roles beyond puberty was unexplored; this established MKRN3 as a tumor-suppressor E3 ligase that non-degradatively ubiquitinates PABPC1 to suppress global protein synthesis and proliferation in lung cancer.","evidence":"MS proteomics, in vitro ubiquitination, reconstitution, two knockout mouse models, and xenografts","pmids":["34143182"],"confidence":"High","gaps":["Relationship between non-K48 PABPC1 ubiquitination in cancer and poly(A) effects in hypothalamus unresolved","Tissue specificity of tumor-suppressor role not defined"]},{"year":2021,"claim":"Variant-level mechanism of disease alleles was incompletely characterized; this showed the p.Gly93Ser mutation attenuates auto-ubiquitination and reduces repression of GNRH1, KISS1, and TAC3 promoters, defining it as loss-of-function.","evidence":"In vitro ubiquitination and GNRH1/KISS1/TAC3 luciferase reporter assays","pmids":["34421985"],"confidence":"Medium","gaps":["No in vivo confirmation of variant effect","Single lab in vitro readouts only"]},{"year":2023,"claim":"Whether MKRN3 shapes hypothalamic structure was unknown; this linked Mkrn3 deletion to increased arcuate dendritic spine density and altered plasticity-gene expression, and identified IGF2BP1 as an interaction partner and NKB as a target.","evidence":"Interactome proteomics, CRISPR knockout mouse with Golgi/spine analysis, iPSC-derived hypothalamic neurons, transcriptomics","pmids":["37092553"],"confidence":"Medium","gaps":["Causal link between spine changes and puberty timing unproven","IGF2BP1 functional consequence of binding not defined"]},{"year":2023,"claim":"How RING versus non-RING mutations affect activity was unclear; this revealed domain-dependent effects, with RING-domain mutations reducing and extra-RING mutations increasing ubiquitination activity.","evidence":"Western blot ubiquitination assays with multiple mutant constructs","pmids":["36916482"],"confidence":"Medium","gaps":["Functional consequence of increased activity not tested in vivo","Single in vitro method"]},{"year":2023,"claim":"The contribution of non-coding regulatory variants and promoter methylation to MKRN3 dosage was uncertain; promoter/5'UTR mutations reduce promoter activity and CpG-island methylation falls prepubertally, indicating multilayered control of MKRN3 expression.","evidence":"Luciferase reporter assays in GT1-7/GN11 cells, in silico TF analysis, and bisulfite sequencing across mouse developmental stages","pmids":["29763903","31636607","36714607"],"confidence":"Medium","gaps":["Direct transcription factors controlling expression not validated","Causal role of methylation changes not tested by perturbation"]},{"year":2023,"claim":"Whether MKRN3 acts in the gonads was unknown; this showed gonadal Mkrn3 expression with peripubertal testicular peak in Leydig cells and gonadotropin-responsive regulation, implying a peripheral arm of action.","evidence":"Gonadal RT-qPCR across development, hCG treatment of primary Leydig cells, and in vivo GnRH agonist administration","pmids":["37585624"],"confidence":"Medium","gaps":["Gonadal substrates and function not defined","Phenotypic consequence of gonadal Mkrn3 loss untested"]},{"year":2025,"claim":"Additional cancer substrates and recruitment mechanisms were undefined; these established that MKRN3 promotes K48-linked STAT3 degradation via the scaffold DLG4 and proteolytically ubiquitinates CSDE1, both restraining tumor proliferation.","evidence":"AP-MS, reciprocal Co-IP, denaturation-IP ubiquitination assays, conditional knockout mouse, and xenografts in lung and ovarian cancer","pmids":["40619404","42204155"],"confidence":"Medium","gaps":["Whether these substrates are regulated in the hypothalamus unknown","Single lab per substrate"]},{"year":2025,"claim":"An environmental trigger for MKRN3 loss was untested; zearalenone-induced MKRN3 auto-ubiquitination and downregulation increased GnRH production in vitro, with GPER implicated.","evidence":"GT1-7 cell treatment, ubiquitination assay, GnRH quantification, and GPER overexpression rescue","pmids":["40726759"],"confidence":"Low","gaps":["Single in vitro system not confirmed in vivo","Mechanistic link between auto-ubiquitination and GnRH effect is indirect"]},{"year":null,"claim":"How MKRN3's multiple molecular activities (transcriptional repression, MBD3-mediated demethylation block, PABP-mediated translational control, plasticity regulation) are integrated and prioritized within the same Kiss1 neuron to time puberty onset remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model assigning relative weight to each repressive mechanism","Endogenous signal that initiates the prepubertal MKRN3 decline upstream of miR-30b unknown","In vivo substrate-specific rescue experiments lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[2,5,6,7,8,15,18]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,6,7,8,15,18]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[5,12]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,6,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,8]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[6,7,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,5,9]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,15,18]}],"complexes":[],"partners":["NPTX1","MBD3","PABPC1","PABPC3","PABPC4","IGF2BP1","STAT3","CSDE1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13064","full_name":"E3 ubiquitin-protein ligase makorin-3","aliases":["RING finger protein 63","RING-type E3 ubiquitin transferase makorin-3","Zinc finger protein 127"],"length_aa":507,"mass_kda":55.6,"function":"E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Acts as a key developmental timer that helps ensure puberty begins at the appropriate age, by inhibiting premature activation of the reproductive hormone cascade. Epigenetically regulates GNRH1 transcription by disrupting the binding of methyl-DNA binding protein 3/MBD3 to the promoter of GNRH1. Mechanistically, mediates the non-proteolytic ubiquitination of MBD3 at multiple sites with 'Lys27' ubiquitin linkages and thereby regulates the methylation status of the genome, including GNRH1 promoter (PubMed:34692086). Modulates the stability and translation of GNRH1 mRNA by mediating the non-proteolytic ubiquitination of PABP family members PABPC1, PABPC3 and PABPC4 at multiple sites (PubMed:33744966). Also participates in the maintenance of genomic and epigenomic stability by regulating the abundance of APEX2 via 'Lys-48'-linked ubiquitination (PubMed:38705397)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13064/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MKRN3","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MKRN3","total_profiled":1310},"omim":[{"mim_id":"615547","title":"SCHAAF-YANG SYNDROME; SHFYNG","url":"https://www.omim.org/entry/615547"},{"mim_id":"615346","title":"PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2","url":"https://www.omim.org/entry/615346"},{"mim_id":"610873","title":"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1","url":"https://www.omim.org/entry/610873"},{"mim_id":"605874","title":"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9","url":"https://www.omim.org/entry/605874"},{"mim_id":"605283","title":"MAGE-LIKE 2; MAGEL2","url":"https://www.omim.org/entry/605283"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":6.1},{"tissue":"retina","ntpm":8.2}],"url":"https://www.proteinatlas.org/search/MKRN3"},"hgnc":{"alias_symbol":["RNF63","ZFP127","MGC88288"],"prev_symbol":["ZNF127","D15S9"]},"alphafold":{"accession":"Q13064","domains":[{"cath_id":"-","chopping":"242-306","consensus_level":"medium","plddt":83.8688,"start":242,"end":306},{"cath_id":"3.30.40.10","chopping":"309-380","consensus_level":"high","plddt":91.3922,"start":309,"end":380}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13064","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13064-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13064-F1-predicted_aligned_error_v6.png","plddt_mean":62.91},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MKRN3","jax_strain_url":"https://www.jax.org/strain/search?query=MKRN3"},"sequence":{"accession":"Q13064","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13064.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13064/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13064"}},"corpus_meta":[{"pmid":"23738509","id":"PMC_23738509","title":"Central precocious puberty caused by mutations in the imprinted gene MKRN3.","date":"2013","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23738509","citation_count":367,"is_preprint":false},{"pmid":"19066619","id":"PMC_19066619","title":"A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19066619","citation_count":100,"is_preprint":false},{"pmid":"25957321","id":"PMC_25957321","title":"A new pathway in the control of the initiation of puberty: the MKRN3 gene.","date":"2015","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25957321","citation_count":95,"is_preprint":false},{"pmid":"32407292","id":"PMC_32407292","title":"MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32407292","citation_count":86,"is_preprint":false},{"pmid":"26431553","id":"PMC_26431553","title":"Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty.","date":"2015","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26431553","citation_count":80,"is_preprint":false},{"pmid":"31041429","id":"PMC_31041429","title":"MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis.","date":"2019","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/31041429","citation_count":80,"is_preprint":false},{"pmid":"24438377","id":"PMC_24438377","title":"Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24438377","citation_count":70,"is_preprint":false},{"pmid":"34692086","id":"PMC_34692086","title":"MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3.","date":"2020","source":"National science review","url":"https://pubmed.ncbi.nlm.nih.gov/34692086","citation_count":68,"is_preprint":false},{"pmid":"33744966","id":"PMC_33744966","title":"MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33744966","citation_count":67,"is_preprint":false},{"pmid":"27225315","id":"PMC_27225315","title":"High Frequency of MKRN3 Mutations in Male Central Precocious Puberty Previously Classified as Idiopathic.","date":"2016","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27225315","citation_count":64,"is_preprint":false},{"pmid":"31697675","id":"PMC_31697675","title":"Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31697675","citation_count":62,"is_preprint":false},{"pmid":"25695892","id":"PMC_25695892","title":"Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25695892","citation_count":61,"is_preprint":false},{"pmid":"25316453","id":"PMC_25316453","title":"A novel MKRN3 missense mutation causing familial precocious puberty.","date":"2014","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25316453","citation_count":59,"is_preprint":false},{"pmid":"25011910","id":"PMC_25011910","title":"MKRN3 mutations in familial central precocious puberty.","date":"2014","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/25011910","citation_count":57,"is_preprint":false},{"pmid":"28672280","id":"PMC_28672280","title":"Molecular Screening of MKRN3, DLK1, and KCNK9 Genes in Girls with Idiopathic Central Precocious Puberty.","date":"2017","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/28672280","citation_count":47,"is_preprint":false},{"pmid":"34143182","id":"PMC_34143182","title":"E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34143182","citation_count":44,"is_preprint":false},{"pmid":"27057785","id":"PMC_27057785","title":"Circulating MKRN3 Levels Decline During Puberty in Healthy Boys.","date":"2016","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27057785","citation_count":43,"is_preprint":false},{"pmid":"25938887","id":"PMC_25938887","title":"Low Frequency of MKRN3 Mutations in Central Precocious Puberty Among Korean Girls.","date":"2015","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/25938887","citation_count":40,"is_preprint":false},{"pmid":"33383582","id":"PMC_33383582","title":"Genotype-Phenotype Correlations in Central Precocious Puberty Caused by MKRN3 Mutations.","date":"2021","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33383582","citation_count":39,"is_preprint":false},{"pmid":"29156706","id":"PMC_29156706","title":"Mkrn3 functions as a novel ubiquitin E3 ligase to inhibit Nptx1 during puberty initiation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29156706","citation_count":39,"is_preprint":false},{"pmid":"26331766","id":"PMC_26331766","title":"A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty.","date":"2015","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/26331766","citation_count":38,"is_preprint":false},{"pmid":"8817070","id":"PMC_8817070","title":"The human/mouse imprinted genes IGF2, H19, SNRPN and ZNF127 map to two conserved autosomal clusters in a marsupial.","date":"1996","source":"Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology","url":"https://pubmed.ncbi.nlm.nih.gov/8817070","citation_count":37,"is_preprint":false},{"pmid":"26173472","id":"PMC_26173472","title":"In silico analysis of a novel MKRN3 missense mutation in familial central precocious puberty.","date":"2015","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26173472","citation_count":33,"is_preprint":false},{"pmid":"30800097","id":"PMC_30800097","title":"MKRN3 Interacts With Several Proteins Implicated in Puberty Timing but Does Not Influence GNRH1 Expression.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30800097","citation_count":32,"is_preprint":false},{"pmid":"29763903","id":"PMC_29763903","title":"Central Precocious Puberty Caused by a Heterozygous Deletion in the MKRN3 Promoter Region.","date":"2018","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29763903","citation_count":29,"is_preprint":false},{"pmid":"27931036","id":"PMC_27931036","title":"Clinical Exome Sequencing Reveals MKRN3 Pathogenic Variants in Familial and Nonfamilial Idiopathic Central Precocious Puberty.","date":"2016","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27931036","citation_count":28,"is_preprint":false},{"pmid":"31636607","id":"PMC_31636607","title":"Central Precocious Puberty Caused by Novel Mutations in the Promoter and 5'-UTR Region of the Imprinted MKRN3 Gene.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31636607","citation_count":25,"is_preprint":false},{"pmid":"28299573","id":"PMC_28299573","title":"MKRN3 levels in girls with central precocious puberty and correlation with sexual hormone levels: a pilot study.","date":"2017","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/28299573","citation_count":25,"is_preprint":false},{"pmid":"8266996","id":"PMC_8266996","title":"Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.","date":"1993","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8266996","citation_count":25,"is_preprint":false},{"pmid":"10395905","id":"PMC_10395905","title":"Imprinted methylation and its effect on expression of the mouse Zfp127 gene.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10395905","citation_count":24,"is_preprint":false},{"pmid":"37092553","id":"PMC_37092553","title":"MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/37092553","citation_count":22,"is_preprint":false},{"pmid":"32228714","id":"PMC_32228714","title":"MKRN3 and KISS1R mutations in precocious and early puberty.","date":"2020","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32228714","citation_count":22,"is_preprint":false},{"pmid":"29537379","id":"PMC_29537379","title":"Investigation of MKRN3 Mutation in Patients with Familial Central Precocious Puberty.","date":"2018","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29537379","citation_count":21,"is_preprint":false},{"pmid":"27798941","id":"PMC_27798941","title":"Two Frameshift Mutations in MKRN3 in Turkish Patients with Familial Central Precocious Puberty.","date":"2016","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27798941","citation_count":21,"is_preprint":false},{"pmid":"31671431","id":"PMC_31671431","title":"Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.","date":"2019","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31671431","citation_count":20,"is_preprint":false},{"pmid":"34414898","id":"PMC_34414898","title":"The role of kisspeptin and MKRN3 in the diagnosis of central precocious puberty in girls.","date":"2021","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/34414898","citation_count":19,"is_preprint":false},{"pmid":"27640350","id":"PMC_27640350","title":"Males with Paternally Inherited MKRN3 Mutations May Be Asymptomatic.","date":"2016","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27640350","citation_count":18,"is_preprint":false},{"pmid":"36187104","id":"PMC_36187104","title":"MKRN3 role in regulating pubertal onset: the state of art of functional studies.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36187104","citation_count":17,"is_preprint":false},{"pmid":"28546864","id":"PMC_28546864","title":"The first Japanese case of central precocious puberty with a novel MKRN3 mutation.","date":"2017","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/28546864","citation_count":17,"is_preprint":false},{"pmid":"32480405","id":"PMC_32480405","title":"Heterozygous Deletions in MKRN3 Cause Central Precocious Puberty Without Prader-Willi Syndrome.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32480405","citation_count":16,"is_preprint":false},{"pmid":"27424312","id":"PMC_27424312","title":"Time Course of Central Precocious Puberty Development Caused by an MKRN3 Gene Mutation: A Prismatic Case.","date":"2016","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27424312","citation_count":16,"is_preprint":false},{"pmid":"36916482","id":"PMC_36916482","title":"Novel MKRN3 Missense Mutations Associated With Central Precocious Puberty Reveal Distinct Effects on Ubiquitination.","date":"2023","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/36916482","citation_count":15,"is_preprint":false},{"pmid":"8669440","id":"PMC_8669440","title":"DNA methylation patterns in human tissues of uniparental origin using a zinc-finger gene (ZNF127) from the Angelman/Prader-Willi region.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8669440","citation_count":15,"is_preprint":false},{"pmid":"31972861","id":"PMC_31972861","title":"Evolutionary Conservation of MKRN3 and Other Makorins and Their Roles in Puberty Initiation and Endocrine Functions.","date":"2020","source":"Seminars in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31972861","citation_count":13,"is_preprint":false},{"pmid":"31687022","id":"PMC_31687022","title":"Low Frequency of MKRN3 and DLK1 Variants in Chinese Children with Central Precocious Puberty.","date":"2019","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31687022","citation_count":13,"is_preprint":false},{"pmid":"30053798","id":"PMC_30053798","title":"Association between MKRN3 and LIN28B polymorphisms and precocious puberty.","date":"2018","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30053798","citation_count":11,"is_preprint":false},{"pmid":"31852205","id":"PMC_31852205","title":"Evaluation of serum makorin ring finger protein 3 (MKRN3) levels in girls with idiopathic central precocious puberty and premature thelarche.","date":"2019","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/31852205","citation_count":10,"is_preprint":false},{"pmid":"30675365","id":"PMC_30675365","title":"(Epi)genetic defects of MKRN3 are rare in Asian patients with central precocious puberty.","date":"2019","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/30675365","citation_count":10,"is_preprint":false},{"pmid":"33214675","id":"PMC_33214675","title":"Familial central precocious puberty: two novel MKRN3 mutations.","date":"2020","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/33214675","citation_count":9,"is_preprint":false},{"pmid":"35748557","id":"PMC_35748557","title":"The Key Roles of Makorin RING Finger Protein 3 (MKRN3) During the Development of Pubertal Initiation and Central Precocious Puberty (CPP).","date":"2023","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35748557","citation_count":9,"is_preprint":false},{"pmid":"32957387","id":"PMC_32957387","title":"A novel heterozygous MKRN3 nonsense mutation in a Chinese girl with idiopathic central precocious puberty: A case report.","date":"2020","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32957387","citation_count":8,"is_preprint":false},{"pmid":"34421985","id":"PMC_34421985","title":"A Novel Loss-of-Function MKRN3 Variant in a Chinese Patient With Familial Precocious Puberty: A Case Report and Functional Study.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34421985","citation_count":8,"is_preprint":false},{"pmid":"36883204","id":"PMC_36883204","title":"Molecular analysis of MKRN3 gene in Turkish girls with sporadic and familial idiopathic central precocious puberty.","date":"2023","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/36883204","citation_count":7,"is_preprint":false},{"pmid":"34359112","id":"PMC_34359112","title":"Conservation of Imprinting and Methylation of MKRN3, MAGEL2 and NDN Genes in Cattle.","date":"2021","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/34359112","citation_count":7,"is_preprint":false},{"pmid":"36438546","id":"PMC_36438546","title":"Six Novel Variants in the MKRN3 Gene Causing Central Precocious Puberty.","date":"2022","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/36438546","citation_count":7,"is_preprint":false},{"pmid":"30269125","id":"PMC_30269125","title":"MKRN3 Levels in Girls with Central Precocious Puberty during GnRHa Treatment: A Longitudinal Study.","date":"2018","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30269125","citation_count":7,"is_preprint":false},{"pmid":"38112911","id":"PMC_38112911","title":"MKRN3 circulating levels in girls with central precocious puberty caused by MKRN3 gene mutations.","date":"2023","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38112911","citation_count":6,"is_preprint":false},{"pmid":"38054352","id":"PMC_38054352","title":"The functional study of a novel MKRN3 missense mutation associated with familial central precocious puberty.","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/38054352","citation_count":6,"is_preprint":false},{"pmid":"36714607","id":"PMC_36714607","title":"Methylation status of hypothalamic Mkrn3 promoter across puberty.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36714607","citation_count":5,"is_preprint":false},{"pmid":"35854182","id":"PMC_35854182","title":"MKRN3 circulating levels in Prader-Willi syndrome: a pilot study.","date":"2022","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35854182","citation_count":5,"is_preprint":false},{"pmid":"33180049","id":"PMC_33180049","title":"Serum level of NPTX1 is independent of serum MKRN3 in central precocious puberty.","date":"2020","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/33180049","citation_count":5,"is_preprint":false},{"pmid":"34689784","id":"PMC_34689784","title":"Elevated expression of MKRN3 in squamous cell carcinoma of the head and neck and its clinical significance.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34689784","citation_count":4,"is_preprint":false},{"pmid":"34297502","id":"PMC_34297502","title":"[Clinical and molecular genetic features of 3 family cases of the central precocious puberty, due to MKRN3 gene defects].","date":"2021","source":"Problemy endokrinologii","url":"https://pubmed.ncbi.nlm.nih.gov/34297502","citation_count":4,"is_preprint":false},{"pmid":"40619404","id":"PMC_40619404","title":"The scaffold protein DLG4 facilitates RNF63-mediated ubiquitination and degradation of STAT3 in non-small cell lung cancer.","date":"2025","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/40619404","citation_count":3,"is_preprint":false},{"pmid":"27091003","id":"PMC_27091003","title":"Conservation of imprinting of MKRN3 and NAP1L5 in rabbits.","date":"2016","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27091003","citation_count":3,"is_preprint":false},{"pmid":"37585624","id":"PMC_37585624","title":"Mouse Testicular Mkrn3 Expression Is Primarily Interstitial, Increases Peripubertally, and Is Responsive to LH/hCG.","date":"2023","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37585624","citation_count":2,"is_preprint":false},{"pmid":"39239972","id":"PMC_39239972","title":"The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population.","date":"2024","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39239972","citation_count":2,"is_preprint":false},{"pmid":"34877345","id":"PMC_34877345","title":"Rare mutation in MKRN3 in two twin sisters with central precocious puberty: Two case reports.","date":"2021","source":"World journal of clinical cases","url":"https://pubmed.ncbi.nlm.nih.gov/34877345","citation_count":2,"is_preprint":false},{"pmid":"40264804","id":"PMC_40264804","title":"Genetic variants of the DLK1, KISS1R, MKRN3 genes in girls with precocious puberty.","date":"2025","source":"Vavilovskii zhurnal genetiki i selektsii","url":"https://pubmed.ncbi.nlm.nih.gov/40264804","citation_count":1,"is_preprint":false},{"pmid":"40231584","id":"PMC_40231584","title":"A Case of Prader-Willi Syndrome With a Deletion Including MAGEL2 , NDN , and MKRN3 , but Excluding SNRPN and SNORD116.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40231584","citation_count":1,"is_preprint":false},{"pmid":"39758341","id":"PMC_39758341","title":"Novel MKRN3 gene mutation associated with central precocious puberty in a Chinese child: a case report.","date":"2024","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/39758341","citation_count":1,"is_preprint":false},{"pmid":"28526651","id":"PMC_28526651","title":"Disruption of NNAT, NAP1L5 and MKRN3 DNA methylation and transcription in rabbit parthenogenetic fetuses.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/28526651","citation_count":1,"is_preprint":false},{"pmid":"39854156","id":"PMC_39854156","title":"A novel model of central precocious puberty disease: Paternal MKRN3 gene-modified rabbit.","date":"2025","source":"Animal models and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39854156","citation_count":1,"is_preprint":false},{"pmid":"39709960","id":"PMC_39709960","title":"Genetic Investigation of Regulatory Regions of <italic>MKRN3</italic> and <italic>DLK1</italic> Genes in Children with Central Precocious Puberty.","date":"2024","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39709960","citation_count":1,"is_preprint":false},{"pmid":"41732517","id":"PMC_41732517","title":"Use of serum MKRN3 and DLK1 levels in precocious puberty: association with an MKRN3 pathogenic variant.","date":"2026","source":"Therapeutic advances in endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/41732517","citation_count":0,"is_preprint":false},{"pmid":"40556973","id":"PMC_40556973","title":"Methylation index of the DLK1 and MKRN3 genes in precocious puberty.","date":"2025","source":"Vavilovskii zhurnal genetiki i selektsii","url":"https://pubmed.ncbi.nlm.nih.gov/40556973","citation_count":0,"is_preprint":false},{"pmid":"42238256","id":"PMC_42238256","title":"Mkrn3, Dlk1, and Mecp2 have distinct hypothalamic expression patterns across pubertal maturation in male and female mice.","date":"2026","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/42238256","citation_count":0,"is_preprint":false},{"pmid":"42204155","id":"PMC_42204155","title":"The central precocious puberty-associated gene MKRN3 is a tumor suppressor regulating CSDE1 ubiquitination in ovarian cancer.","date":"2026","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/42204155","citation_count":0,"is_preprint":false},{"pmid":"40726759","id":"PMC_40726759","title":"Zearalenone induces GnRH neurons activation related to central precocious puberty by triggering MKRN3 auto-ubiquitination and down-regulation.","date":"2025","source":"Toxicology research","url":"https://pubmed.ncbi.nlm.nih.gov/40726759","citation_count":0,"is_preprint":false},{"pmid":"41950159","id":"PMC_41950159","title":"MKRN3 variants in central precocious puberty as an example of the complexity to classify missense variants in imprinted genes as pathogenic.","date":"2026","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41950159","citation_count":0,"is_preprint":false},{"pmid":"41642464","id":"PMC_41642464","title":"Divergent epigenetic profile underlie pubertal disorders in MKRN3-associated central precocious puberty and Prader-Willi syndrome: insights from a frameshift variant.","date":"2026","source":"World journal of pediatrics : WJP","url":"https://pubmed.ncbi.nlm.nih.gov/41642464","citation_count":0,"is_preprint":false},{"pmid":"41264570","id":"PMC_41264570","title":"Phenotypic Variability of Males with Loss-of-Function Mutations of <italic>MKRN3</italic>: A Case Report and Literature Review.","date":"2025","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41264570","citation_count":0,"is_preprint":false},{"pmid":"41323096","id":"PMC_41323096","title":"Outcomes of Patients With Familial Central Precocious Puberty due to Mutations of MKRN3 Gene After Treatment With Gonadotropin-Releasing Hormone Agonist.","date":"2025","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/41323096","citation_count":0,"is_preprint":false},{"pmid":"1679924","id":"PMC_1679924","title":"A BsaBI RFLP detected for probe pML34 [D15S9] on chromosome 15q.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1679924","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.29.615689","title":"UBE3A reinstatement restores behavior and proteome in an Angelman Syndrome mouse model of Imprinting Defects","date":"2024-10-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.29.615689","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44543,"output_tokens":5462,"usd":0.10778,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13753,"output_tokens":5214,"usd":0.099557,"stage2_stop_reason":"end_turn"},"total_usd":0.207337,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss-of-function mutations in MKRN3 (frameshift and missense) cause central precocious puberty in humans; MKRN3 mRNA is high in the arcuate nucleus of prepubertal mice and decreases immediately before puberty, establishing an inhibitory role on GnRH secretion.\",\n      \"method\": \"Whole-exome sequencing, Sanger sequencing, quantitative real-time PCR in mouse hypothalami at different ages\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple families with segregation analysis consistent with imprinted inheritance, mRNA expression profiling across developmental stages, replicated extensively across subsequent studies\",\n      \"pmids\": [\"23738509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The mouse Zfp127 (Mkrn3) gene is differentially methylated with the maternal allele methylated and the paternal allele unmethylated; maternal methylation is established promptly after fertilization prior to syngamy; in methyltransferase-deficient mice Zfp127 is biallelically expressed, demonstrating that methylation enforces paternal-only expression.\",\n      \"method\": \"Bisulfite sequencing / methylation analysis, methyltransferase-deficient mouse model, expression analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct methylation mapping and genetic model (methyltransferase-deficient mice) with functional consequence on monoallelic expression\",\n      \"pmids\": [\"10395905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MKRN3 (Mkrn3) functions as an E3 ubiquitin ligase that interacts with and polyubiquitinates Nptx1 (neural pentraxin 1) in the mouse hypothalamus; the RING finger domain of Mkrn3 is required for binding Nptx1 and catalyzing its polyubiquitination; Mkrn3 and Nptx1 show inverse expression patterns in the hypothalamus around puberty initiation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, RING finger domain deletion analysis, expression profiling in mouse hypothalamus\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and in vitro ubiquitination assay with domain deletion, single lab\",\n      \"pmids\": [\"29156706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hypothalamic miR-30b directly represses Mkrn3 via three binding sites in a highly conserved region of the Mkrn3 3' UTR; hypothalamic miR-30b expression increases while Mkrn3 protein decreases during rat postnatal maturation; central infusion of target site blockers preventing miR-30 binding to Mkrn3 3' UTR reversed the prepubertal decline in hypothalamic Mkrn3 protein and delayed female puberty onset.\",\n      \"method\": \"In vitro luciferase reporter assay (3' UTR), central infusion of target site blockers (TSBs) in juvenile rats, western blot, qPCR\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — functional luciferase validation plus in vivo TSB intervention with direct phenotypic readout, multiple orthogonal methods\",\n      \"pmids\": [\"31697675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MKRN3 interacts with 81 high-confidence protein partners identified by mass spectrometry in HEK cells, including proteins involved in insulin signaling, RNA metabolism, and cell-cell adhesion, of which 20 have been previously implicated in puberty timing. MKRN3 knockout in human iPSC-derived GnRH neurons did not alter GNRH1 expression (negative finding).\",\n      \"method\": \"Stable expression in HEK cells followed by mass spectrometry (AP-MS), human iPSC differentiation into GnRH neurons with CRISPR knockout\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-based interactome screen with stable expression, plus negative functional result in iPSC model, single lab\",\n      \"pmids\": [\"30800097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MKRN3 is expressed in Kiss1 neurons of the mouse hypothalamic arcuate nucleus and represses promoter activity of human KISS1 and TAC3. MKRN3 has intrinsic ubiquitinase (E3 ligase) activity, which is reduced by mutations affecting the RING finger domain; these RING finger mutations also compromise repression of KISS1 and TAC3 promoter activity. MKRN3 expression in the hypothalamus of rats and non-human primates is high early in life and decreases as puberty approaches, independent of sex steroids.\",\n      \"method\": \"In situ hybridization (Mkrn3 and Kiss1 co-localization), luciferase promoter reporter assays (KISS1 and TAC3), in vitro ubiquitination assay, RING finger domain mutagenesis, expression profiling across developmental stages in multiple species\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (co-localization, reporter assay, in vitro ubiquitination, mutagenesis) in a single rigorous study\",\n      \"pmids\": [\"32407292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MKRN3 interacts with and ubiquitinates MBD3 (methyl-CpG binding domain protein 3); this ubiquitination disrupts MBD3 binding to the GNRH1 promoter and prevents recruitment of DNA demethylase TET2, thereby epigenetically silencing GNRH1 transcription. Genetic ablation of Mkrn3 in mice accelerates puberty onset with increased hypothalamic GnRH1 production.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, chromatin immunoprecipitation, Mkrn3 knockout mouse model, hypothalamic GnRH1 quantification\",\n      \"journal\": \"National science review\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — Co-IP, ubiquitination assay, ChIP, and in vivo knockout with phenotypic readout in single study, multiple orthogonal methods\",\n      \"pmids\": [\"34692086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MKRN3 ubiquitinates three poly(A)-binding proteins (PABPC1, PABPC3, and PABPC4); this ubiquitination attenuates PABP binding to poly(A) tails of mRNA, shortens the poly(A) tail length of GNRH1 mRNA, and compromises formation of the translation initiation complex, thereby suppressing GNRH1 mRNA translation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, poly(A) tail length assay, translation initiation complex analysis, mass spectrometry substrate identification\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of ubiquitination, poly(A) tail assay, and TIC assay; multiple orthogonal methods in single study\",\n      \"pmids\": [\"33744966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MKRN3 functions as a tumor suppressor E3 ubiquitin ligase in non-small cell lung cancer (NSCLC); PABPC1 was identified as a major substrate for MKRN3 via mass spectrometry proteomics. MKRN3 modulates cell proliferation through nonproteolytic (non-K48) ubiquitination of PABPC1 and subsequent suppression of PABPC1-mediated global protein synthesis. MKRN3 missense mutations identified in patients substantially compromise MKRN3-mediated PABPC1 ubiquitination. Mkrn3 knockout mice show increased susceptibility to urethane-induced lung cancer.\",\n      \"method\": \"Mass spectrometry proteomics, in vitro ubiquitination assay, western blot, reconstitution of MKRN3 in knockout cells, MKRN3 knockout mouse (urethane-induced and lung cell-specific), tumor xenograft\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — MS substrate identification, in vitro ubiquitination, multiple in vivo models (two KO mouse models, xenograft), reconstitution experiments\",\n      \"pmids\": [\"34143182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MKRN3 interacts with IGF2BP1 (insulin-like growth factor 2 mRNA-binding protein 1), identified by proteomics; IGF2BP1 in turn interacts with polyadenylate-binding protein family members. Mkrn3 deletion in a mouse model leads to early puberty onset in female mice and increases dendritic spine number in the arcuate nucleus without altering GnRH neuron morphology. Mkrn3 deletion also results in significant changes in expression of genes controlling hypothalamic development and plasticity in human iPSC-derived hypothalamic neurons. Neurokinin B (NKB) was identified as an Mkrn3 target.\",\n      \"method\": \"Proteomics (interactome analysis), CRISPR knockout mouse model, Golgi staining / spine density analysis, human iPSC-derived hypothalamic neurons with MKRN3 deletion, transcriptomics\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — interactome proteomics plus in vivo KO phenotype and iPSC model, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37092553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A heterozygous 4-nucleotide deletion in the proximal promoter region of MKRN3 (c.-150_-147delTCAG) reduces MKRN3 promoter activity in GT1-7 cells as demonstrated by luciferase reporter assay; in silico analysis predicts loss of a DREAM transcription factor binding site.\",\n      \"method\": \"Luciferase reporter assay in GT1-7 cells, Sanger sequencing, in silico transcription factor binding analysis\",\n      \"journal\": \"Neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay with mutant and wild-type promoter constructs, single lab, single method\",\n      \"pmids\": [\"29763903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Novel mutations in the proximal promoter region of MKRN3 (-166, -865, -886 nt upstream of TSS) significantly reduce MKRN3 promoter activity in GN11 cells as shown by luciferase reporter assay; a 5'-UTR mutation (+13 nt downstream of TSS) is predicted to destabilize mRNA secondary structure by in silico analysis.\",\n      \"method\": \"Luciferase reporter assay in GN11 cells, Sanger sequencing, in silico mRNA secondary structure analysis\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter assay with multiple mutant constructs, single lab\",\n      \"pmids\": [\"31636607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Novel MKRN3 missense mutations within the RING finger domain reduced ubiquitination activity compared to wild-type MKRN3, whereas mutations outside the RING finger domain increased ubiquitination, revealing distinct domain-dependent effects on E3 ligase activity.\",\n      \"method\": \"Western blot ubiquitination assay with mutant and wild-type MKRN3 constructs\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro ubiquitination assay with multiple mutant constructs, single lab, single method\",\n      \"pmids\": [\"36916482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A novel MKRN3 missense mutation (p.Gly93Ser) attenuates MKRN3 auto-ubiquitination and degradation, and reduces inhibition of GNRH1, KISS1, and TAC3 promoter transcriptional activity, establishing it as a loss-of-function mutation that compromises MKRN3's repression of GnRH-related signaling.\",\n      \"method\": \"In vitro ubiquitination assay, luciferase promoter reporter assays (GNRH1, KISS1, TAC3)\",\n      \"journal\": \"Frontiers in genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays with ubiquitination and reporter assay, single lab, two orthogonal methods\",\n      \"pmids\": [\"34421985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A novel MKRN3 variant (p.Arg327His) attenuates MKRN3 auto-ubiquitination, degradation, and inhibition of GNRH1 transcriptional and translational activity, confirming loss-of-function for this variant.\",\n      \"method\": \"In vitro ubiquitination assay, luciferase reporter assay, translational activity assay\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays (ubiquitination, transcription, translation), single lab\",\n      \"pmids\": [\"38054352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MKRN3 (RNF63) directly interacts with STAT3 and promotes its K48-linked polyubiquitination and proteasome-mediated degradation in NSCLC cells; scaffold protein DLG4 recruits RNF63/MKRN3 to STAT3 to facilitate this ubiquitination. In human NSCLC specimens, DLG4 and RNF63 expression levels are inversely correlated with STAT3 levels.\",\n      \"method\": \"Affinity purification mass spectrometry, co-immunoprecipitation, denaturation-IP (ubiquitination assay), immunohistochemistry, cell proliferation assays\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, denaturation-IP for ubiquitination, AP-MS substrate identification, single lab\",\n      \"pmids\": [\"40619404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The CpG island within the Mkrn3 promoter shows significantly lower methylation levels at the pre-pubertal stage compared to pubertal or post-pubertal stages in female mouse hypothalamus, suggesting differential promoter methylation regulates Mkrn3 expression during puberty. In silico analysis identified 14 transcriptional repressors among 29 predicted transcription factor binding sites in the CpG islet region.\",\n      \"method\": \"Bisulfite sequencing of mouse hypothalamus at multiple developmental stages, CpG mapping, in silico transcription factor binding analysis\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct bisulfite sequencing across developmental time points in vivo, single lab\",\n      \"pmids\": [\"36714607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mkrn3 mRNA is expressed in testes and ovaries of mice at all ages; testicular Mkrn3 is expressed primarily in the interstitial (Leydig cell) compartment; testicular Mkrn3 expression peaks peripubertally in males and is upregulated by LH/hCG stimulation in a dose-dependent manner in primary Leydig cell cultures; acute GnRH agonist administration increases testicular Mkrn3, while chronic GnRH agonist suppresses it.\",\n      \"method\": \"RT-qPCR in gonads across developmental stages, in vitro hCG treatment of primary Leydig cell cultures, in vivo acute and chronic GnRH agonist administration in adult mice\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro LH/hCG dose-response and in vivo pharmacological manipulation with mRNA readout, single lab\",\n      \"pmids\": [\"37585624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MKRN3 (RNF63) ubiquitinates CSDE1 (cold shock domain-containing E1) via proteolytic (degradative) ubiquitination, identified as a major substrate in ovarian cancer cells by mass spectrometry proteomics; MKRN3-mediated CSDE1 degradation suppresses OC cell proliferation; ovary-specific Mkrn3 knockout in mice accelerates P53 inactivation-induced tumorigenesis.\",\n      \"method\": \"Mass spectrometry proteomics, in vitro ubiquitination assay, ovary-specific conditional knockout mouse model, tumor xenograft, in vitro proliferation assays\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — MS substrate identification, ubiquitination assay, in vivo conditional KO mouse, single lab\",\n      \"pmids\": [\"42204155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Zearalenone (ZEA) treatment of hypothalamic GT1-7 cells triggers MKRN3 auto-ubiquitination and down-regulation, which leads to increased GnRH production and cell proliferation; GPER (G protein-coupled estrogen receptor) re-localization is associated with this effect and GPER overexpression attenuates ZEA-induced changes.\",\n      \"method\": \"In vitro cell treatment (GT1-7 cells), ubiquitination assay, GnRH quantification, GPER localization analysis, GPER overexpression rescue experiment\",\n      \"journal\": \"Toxicology research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single in vitro system, single lab, mechanistic link between auto-ubiquitination and GnRH effects is indirect\",\n      \"pmids\": [\"40726759\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MKRN3 is a paternally expressed, maternally imprinted E3 ubiquitin ligase that acts as a brake on puberty initiation by repressing GnRH secretion through multiple mechanisms: it is expressed in hypothalamic Kiss1 neurons where it represses KISS1 and TAC3 promoter activity via its RING finger-dependent ubiquitinase activity; it epigenetically silences GNRH1 transcription by ubiquitinating MBD3 to disrupt TET2 recruitment; it suppresses GNRH1 mRNA translation by ubiquitinating poly(A)-binding proteins (PABPC1/3/4) to shorten poly(A) tails and impair translation initiation; it interacts with IGF2BP1 and regulates hypothalamic plasticity; and its hypothalamic expression—enforced by differential DNA methylation (maternal allele methylated) and regulated post-transcriptionally by miR-30b—declines before puberty onset, thereby permitting GnRH secretion to rise; loss-of-function mutations in MKRN3 are the most common known genetic cause of familial central precocious puberty.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MKRN3 is a paternally expressed, maternally imprinted RING-finger E3 ubiquitin ligase that acts as a developmental brake on puberty initiation by restraining hypothalamic GnRH secretion [#0, #5]. Its monoallelic expression is enforced by differential DNA methylation, with the maternal allele methylated and the paternal allele active, established shortly after fertilization [#1]. MKRN3 is expressed in Kiss1 neurons of the arcuate nucleus, where its RING-finger-dependent ubiquitinase activity represses transcription from the KISS1 and TAC3 promoters [#5]. It silences the GnRH axis through multiple converging mechanisms: it ubiquitinates the methyl-CpG-binding protein MBD3 to block TET2 recruitment and epigenetically repress GNRH1 transcription [#6], and it ubiquitinates the poly(A)-binding proteins PABPC1/3/4 to shorten GNRH1 mRNA poly(A) tails and impair translation initiation [#7]. Hypothalamic MKRN3 protein is high early in life and declines before puberty; this decline is driven by miR-30b, which directly represses MKRN3 via conserved 3'UTR sites, and blocking miR-30 binding sustains MKRN3 and delays puberty [#3]. Loss-of-function mutations in MKRN3 — frameshift, missense, and promoter variants that reduce its expression or RING-dependent ligase activity — are a common genetic cause of familial central precocious puberty, and genetic ablation of Mkrn3 in mice accelerates puberty onset [#0, #6, #13]. Beyond the reproductive axis, MKRN3 functions as a tumor-suppressor E3 ligase, ubiquitinating PABPC1, STAT3, and CSDE1 to restrain cell proliferation [#8, #15, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Before MKRN3's function was known, the basis of its monoallelic expression was unresolved; this established that genomic imprinting via maternal-allele DNA methylation enforces paternal-only expression.\",\n      \"evidence\": \"Bisulfite methylation mapping and methyltransferase-deficient mouse model with allelic expression analysis\",\n      \"pmids\": [\"10395905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect imprinted expression to any physiological function\", \"Methylation dynamics in human hypothalamus not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The physiological role of MKRN3 was unknown until human genetics linked it to puberty; this established MKRN3 as an inhibitory brake on GnRH secretion whose loss causes central precocious puberty.\",\n      \"evidence\": \"Whole-exome and Sanger sequencing in families with central precocious puberty plus developmental qPCR of mouse hypothalamus\",\n      \"pmids\": [\"23738509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of inhibition not defined\", \"Cellular site of action within hypothalamus not pinpointed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"How MKRN3 acts biochemically was unclear; this provided the first evidence that MKRN3 is an active E3 ligase, polyubiquitinating Nptx1 via its RING finger in the hypothalamus.\",\n      \"evidence\": \"Reciprocal Co-IP, in vitro ubiquitination assay, and RING-domain deletion in mouse hypothalamus\",\n      \"pmids\": [\"29156706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between Nptx1 ubiquitination and GnRH secretion not established\", \"Single lab, no in vivo loss-of-function for this substrate\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"What drives the prepubertal fall in MKRN3 was unknown; this identified miR-30b as a direct post-transcriptional repressor whose blockade sustains MKRN3 and delays puberty.\",\n      \"evidence\": \"3'UTR luciferase reporter assays plus central infusion of target-site blockers in juvenile rats with phenotypic readout\",\n      \"pmids\": [\"31697675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream control of miR-30b induction unknown\", \"Interplay with promoter methylation not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The MKRN3 interactome and its requirement in GnRH neurons were undefined; this catalogued 81 candidate partners and showed MKRN3 knockout in iPSC-derived GnRH neurons did not alter GNRH1, indicating action upstream rather than cell-autonomously in GnRH neurons.\",\n      \"evidence\": \"AP-MS interactome in HEK cells plus CRISPR knockout in human iPSC-derived GnRH neurons\",\n      \"pmids\": [\"30800097\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most interactions unvalidated and possibly overexpression artifacts\", \"Negative GNRH1 result not mechanistically explained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The cellular site and direct transcriptional targets were uncertain; this localized MKRN3 to arcuate Kiss1 neurons and demonstrated RING-dependent repression of KISS1 and TAC3 promoters with conserved cross-species developmental decline.\",\n      \"evidence\": \"In situ co-localization, KISS1/TAC3 luciferase reporters, in vitro ubiquitination, RING mutagenesis across rodent and primate developmental stages\",\n      \"pmids\": [\"32407292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ubiquitination substrate linking to KISS1/TAC3 repression not identified in this study\", \"Mechanism of promoter repression incompletely defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How MKRN3 silences GNRH1 transcription was unknown; this showed MKRN3 ubiquitinates MBD3 to block TET2 recruitment and demethylation of the GNRH1 promoter, with Mkrn3 knockout accelerating puberty in vivo.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, ChIP, and Mkrn3 knockout mouse with hypothalamic GnRH1 quantification\",\n      \"pmids\": [\"34692086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Linkage type of MBD3 ubiquitination not detailed\", \"Relative contribution versus translational control unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A translational mode of GnRH suppression was undefined; this showed MKRN3 ubiquitinates PABPC1/3/4 to shorten GNRH1 poly(A) tails and impair translation initiation complex formation.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, poly(A) tail length assay, translation initiation complex analysis, MS substrate identification\",\n      \"pmids\": [\"33744966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation of GNRH1 translation effect not shown\", \"Selectivity for GNRH1 mRNA over global mRNA not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Whether MKRN3 has roles beyond puberty was unexplored; this established MKRN3 as a tumor-suppressor E3 ligase that non-degradatively ubiquitinates PABPC1 to suppress global protein synthesis and proliferation in lung cancer.\",\n      \"evidence\": \"MS proteomics, in vitro ubiquitination, reconstitution, two knockout mouse models, and xenografts\",\n      \"pmids\": [\"34143182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between non-K48 PABPC1 ubiquitination in cancer and poly(A) effects in hypothalamus unresolved\", \"Tissue specificity of tumor-suppressor role not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Variant-level mechanism of disease alleles was incompletely characterized; this showed the p.Gly93Ser mutation attenuates auto-ubiquitination and reduces repression of GNRH1, KISS1, and TAC3 promoters, defining it as loss-of-function.\",\n      \"evidence\": \"In vitro ubiquitination and GNRH1/KISS1/TAC3 luciferase reporter assays\",\n      \"pmids\": [\"34421985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo confirmation of variant effect\", \"Single lab in vitro readouts only\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether MKRN3 shapes hypothalamic structure was unknown; this linked Mkrn3 deletion to increased arcuate dendritic spine density and altered plasticity-gene expression, and identified IGF2BP1 as an interaction partner and NKB as a target.\",\n      \"evidence\": \"Interactome proteomics, CRISPR knockout mouse with Golgi/spine analysis, iPSC-derived hypothalamic neurons, transcriptomics\",\n      \"pmids\": [\"37092553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between spine changes and puberty timing unproven\", \"IGF2BP1 functional consequence of binding not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"How RING versus non-RING mutations affect activity was unclear; this revealed domain-dependent effects, with RING-domain mutations reducing and extra-RING mutations increasing ubiquitination activity.\",\n      \"evidence\": \"Western blot ubiquitination assays with multiple mutant constructs\",\n      \"pmids\": [\"36916482\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of increased activity not tested in vivo\", \"Single in vitro method\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The contribution of non-coding regulatory variants and promoter methylation to MKRN3 dosage was uncertain; promoter/5'UTR mutations reduce promoter activity and CpG-island methylation falls prepubertally, indicating multilayered control of MKRN3 expression.\",\n      \"evidence\": \"Luciferase reporter assays in GT1-7/GN11 cells, in silico TF analysis, and bisulfite sequencing across mouse developmental stages\",\n      \"pmids\": [\"29763903\", \"31636607\", \"36714607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcription factors controlling expression not validated\", \"Causal role of methylation changes not tested by perturbation\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether MKRN3 acts in the gonads was unknown; this showed gonadal Mkrn3 expression with peripubertal testicular peak in Leydig cells and gonadotropin-responsive regulation, implying a peripheral arm of action.\",\n      \"evidence\": \"Gonadal RT-qPCR across development, hCG treatment of primary Leydig cells, and in vivo GnRH agonist administration\",\n      \"pmids\": [\"37585624\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Gonadal substrates and function not defined\", \"Phenotypic consequence of gonadal Mkrn3 loss untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Additional cancer substrates and recruitment mechanisms were undefined; these established that MKRN3 promotes K48-linked STAT3 degradation via the scaffold DLG4 and proteolytically ubiquitinates CSDE1, both restraining tumor proliferation.\",\n      \"evidence\": \"AP-MS, reciprocal Co-IP, denaturation-IP ubiquitination assays, conditional knockout mouse, and xenografts in lung and ovarian cancer\",\n      \"pmids\": [\"40619404\", \"42204155\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these substrates are regulated in the hypothalamus unknown\", \"Single lab per substrate\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"An environmental trigger for MKRN3 loss was untested; zearalenone-induced MKRN3 auto-ubiquitination and downregulation increased GnRH production in vitro, with GPER implicated.\",\n      \"evidence\": \"GT1-7 cell treatment, ubiquitination assay, GnRH quantification, and GPER overexpression rescue\",\n      \"pmids\": [\"40726759\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single in vitro system not confirmed in vivo\", \"Mechanistic link between auto-ubiquitination and GnRH effect is indirect\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MKRN3's multiple molecular activities (transcriptional repression, MBD3-mediated demethylation block, PABP-mediated translational control, plasticity regulation) are integrated and prioritized within the same Kiss1 neuron to time puberty onset remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model assigning relative weight to each repressive mechanism\", \"Endogenous signal that initiates the prepubertal MKRN3 decline upstream of miR-30b unknown\", \"In vivo substrate-specific rescue experiments lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [2, 5, 6, 7, 8, 15, 18]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 6, 7, 8, 15, 18]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [5, 12]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 6, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 7, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 5, 9]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 15, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NPTX1\", \"MBD3\", \"PABPC1\", \"PABPC3\", \"PABPC4\", \"IGF2BP1\", \"STAT3\", \"CSDE1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}